Human vascular smooth muscle cells possess functional CCR5.
about
Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discoveryEmerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV propertiesPattern specification and immune response transcriptional signatures of pericardial and subcutaneous adipose tissueRecruitment of CXCR3+ and CCR5+ T cells and production of interferon-gamma-inducible chemokines in rejecting human arteries.T cells in cardiac allograft vasculopathy are skewed to memory Th-1 cells in the presence of a distinct Th-2 population.Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice.Induced Pluripotent Stem Cell-Derived Endothelial Cells Overexpressing Interleukin-8 Receptors A/B and/or C-C Chemokine Receptors 2/5 Inhibit Vascular Injury ResponseHIV envelope gp120 activates human arterial smooth muscle cells.Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene.CCR5 receptor: biologic and genetic implications in age-related diseases.Chemokine receptor CCR5: from AIDS to atherosclerosisGenes and abdominal aortic aneurysm.Stem cell origins of intimal cells in graft arterial disease.Inhibition of intimal hyperplasia in transgenic mice conditionally expressing the chemokine-binding protein M3.CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort studyCannabinoid receptors in acute and chronic complications of atherosclerosis.Fatigue-induced Orosomucoid 1 Acts on C-C Chemokine Receptor Type 5 to Enhance Muscle EnduranceHuman immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular diseaseCCR5 deletion protects against inflammation-associated mortality in dialysis patients.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging.The CCR5 chemokine receptor mediates vasoconstriction and stimulates intimal hyperplasia in human vessels in vitro.Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases.Clinical utility of maraviroc.The duality of chemokines in heart failure.Novel Targets of Drug Treatment for Pulmonary Hypertension.Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype.Localization and enhanced mRNA expression of the orphan chemokine receptor L-CCR in the lung in a murine model of ovalbumin-induced airway inflammation.CCR5 as a treatment target in pulmonary arterial hypertension.Systemic administration of kainic acid in adult rat stimulates expression of the chemokine receptor CCR5 in the forebrain.Structure-function studies on non-synonymous SNPs of chemokine receptor gene implicated in cardiovascular disease: a computational approach.Polymorphisms of chemokine receptors and eNOS in Brazilian patients with sickle cell disease.
P2860
Q21285000-A21C2335-77F5-4B00-8B43-BEA22483BA60Q26739691-5A68307D-7206-4E0D-98F9-CDD47D564754Q28344956-D8A9B9C0-82D6-4DA0-9329-BD747CEF6A5DQ28744049-A6E80D99-5462-49D8-AB17-062D0A8555F5Q33214938-19F96B8C-5A70-428F-BE65-249805A09288Q33328649-DF6368FD-5CBF-444E-96DC-62CB9212757DQ33559676-89FE5A68-59D4-4B9F-9028-FD63FFC3C15EQ33722663-A977A732-07DB-4632-89F3-1B3AD5075614Q33943009-21B52F1D-3837-42E0-8CBD-B943E0667D23Q34161676-CFD3221C-4F1B-4C7B-999D-E392DFE6C2C1Q34622935-D106F3CE-6561-4934-8B73-91A56802B918Q34672038-84599D5B-254A-40E7-99E1-2D9AF7CC0A1FQ34683905-05DB2298-9294-4AEA-8C4F-999CE400AF8FQ35095437-7782D131-3602-4BF6-A20E-2EC0C35203E8Q35098401-4CDBEF57-6893-4DBC-9308-9BF8FAB87B55Q35617726-7F6E8D33-3E5E-47C8-9A7F-86A4C21D26F2Q36416368-FD833FC7-BBF3-440A-B3D8-B04685493DAEQ36438411-D4878B47-44FA-4981-97AE-9FD67BFCB911Q36512300-1989488A-B7C6-47D2-ABCA-ECAC12F43091Q37259261-B5A9276D-ACBA-4F64-8241-BC9AA7E7DEF4Q37432097-9864DFDB-6AB4-4D3E-89F7-58A48C7BC838Q37450201-41CA4CDF-4C3E-427F-A1AA-AB5A9FDD6280Q37591226-4E82AA82-C63E-4E5C-BA01-CE25AEA0848CQ37723178-59C10E62-BF9B-49CF-B0EE-BF75B1A4996FQ37877242-86664885-74DF-457F-81FF-5CE8526426A9Q38375149-9CEC9C43-4D5D-4830-8E36-B72991C7D46FQ38504399-9437485F-F63E-4CF3-82EA-DFAEC7BC31D6Q38674677-B125C88B-5A67-43B2-9278-45F251A141F1Q40589587-35B206AA-BFD9-47BB-82D8-BD3197410D08Q42020850-BCA490E4-48A0-4F3D-9E05-9AE071677D8EQ43831369-F4EF6C27-70DF-41B2-A2AC-CA530D57CB89Q45405994-CDEBB077-2FBB-463B-A360-198D60C81F99Q54630130-94F773BF-97B8-41BF-BF92-2AA4EF1FA31A
P2860
Human vascular smooth muscle cells possess functional CCR5.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Human vascular smooth muscle cells possess functional CCR5.
@en
Human vascular smooth muscle cells possess functional CCR5.
@nl
type
label
Human vascular smooth muscle cells possess functional CCR5.
@en
Human vascular smooth muscle cells possess functional CCR5.
@nl
prefLabel
Human vascular smooth muscle cells possess functional CCR5.
@en
Human vascular smooth muscle cells possess functional CCR5.
@nl
P2093
P2860
P356
P1476
Human vascular smooth muscle cells possess functional CCR5.
@en
P2093
Calderon TM
McManus CM
Rossikhina M
Schecter AD
Taubman MB
P2860
P304
P356
10.1074/JBC.275.8.5466
P407
P577
2000-02-01T00:00:00Z